PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGF

Robert Hnasko1, John Mark Carter, Freddy Medina

  • 1United States Department of Agriculture, Agricultural Research Service-Pacific West Area, Western Region Research Center, Foodborne Contaminants Research Unit, Albany, California, USA.

Insights

The PV-1 protein plays a key role in forming transendothelial channels and altering nuclear shape in MS-1 cells. Vascular endothelial growth factor (VEGF) appears to negatively regulate PV-1 protein levels.

Area of Science:

  • Endothelial cell biology
  • Protein biochemistry
  • Molecular cell biology

Background:

  • The PV-1 protein is endogenously expressed in mouse pancreatic MS-1 endothelial cells.
  • PV-1 exists as N-glycosylated (60-kDa) and non-glycosylated (50-kDa) forms, forming DTT-sensitive oligomers.
  • Antibodies against PV-1 label transcellular openings and intracellular aggregates in non-permeabilized cells.

Purpose of the Study:

  • To investigate the functional role of PV-1 in endothelial cell structure and regulation.
  • To explore the relationship between PV-1, transendothelial channels, nuclear shape, and VEGF signaling.

Main Methods:

  • Immunofluorescence labeling of PV-1 in MS-1 cells.
  • Analysis of PV-1 protein expression and oligomerization.
  • Treatment with VEGF-R2 inhibitor SU5614 to assess effects on PV-1 levels and cell growth.
  • Microscopy to observe cellular and nuclear morphology.

Main Results:

  • PV-1 antibodies revealed transcellular openings and intracellular fibrous networks, sometimes deforming the nucleus.
  • SU5614 treatment increased PV-1 protein levels and inhibited MS-1 cell growth without inducing apoptosis.
  • PV-1 protein levels were found to be negatively regulated by VEGF.

Conclusions:

  • PV-1 is functionally involved in the formation of transendothelial channels and modulation of nuclear shape.
  • VEGF negatively regulates PV-1 protein expression, suggesting a role in endothelial barrier function and cell morphology.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...